Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Locations were updated: new site entries by state and country (California, Florida, Kansas, Kentucky, Minnesota, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Washington, Ontario, Quebec) were added and corresponding per-location headings were removed, with a revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:50:01.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    PubMed data section note updated to indicate publications are automatically filled from PubMed. Revision version updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:08:46.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Removed the government funding status notice that warned about potential delays and NIH operating status; this is a non-critical update that does not affect core study details or participant actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T18:30:53.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The two screenshots show the same Study Details page for NCT02118337 with identical content and layout. No substantive differences are detected.
    Difference
    0.3%
    Check dated 2025-11-03T13:05:44.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    - Added a government funding/operating status notice and current NIH Clinical Center information; updated version to v3.2.0. - Removed reference to v3.1.0.
    Difference
    1%
    Check dated 2025-10-05T17:41:58.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Content update: terminology refined from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a new version tag v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T11:12:34.000Z thumbnail image

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.